safety
Recall alert: Vitruvias Therapeutics recalls thyroid tablets over ‘superpotent’ concerns
Summary by The Atlanta Editorial Desk Bob D'Angelo, Cox Media Group National Content Desk , as published by WSB-TV (ABC) - News
· August 26, 2026
· 1 min read
Photo: WSB-TV (ABC) - News · view original
Story provenance No corrections
Summary created by The Atlanta Editorial Desk — automated, rule-governed Byline on source page Bob D'Angelo, Cox Media Group National Content Desk, as published by WSB-TV (ABC) - News Original story Read at the source Source published Aug 26, 2026 Indexed here Aug 26, 2026 AI assistance Automated summary drawn from the source’s own published text Prepublication human review No — editorial rules, flagged-item review, and published samples
Every story comes with a passport. How we work · Corrections log · Publisher’s note
Key points The recall affects 30-milligram thyroid tablets, specifically Lot 504950, which was distributed nationwide. This lot had an expiration date of September 30, 2026, and was distributed from January 31, 2025, to September 30, 2025.
A recall has been issued for a thyroid pill due to concerns it may be "superpotent". The recall affects 30-milligram thyroid tablets, specifically Lot 504950, which was distributed nationwide. This lot had an expiration date of September 30, 2026, and was distributed from January 31, 2025, to September 30, 2025.
The recall was announced by Vitruvias Therapeutics Inc. and posted on the US Food and Drug Administration website. Further details about the recall can be found on the FDA website.
The company is based in Auburn, Alabama, and the recall is nationwide, indicating that the affected tablets may have been distributed to various locations.
More safety Today’s briefing Local events
Why this story is here
WSB-TV (ABC) - News reported and published this story. The Atlanta selected it, summarised the key facts above, and links to the original. We did not report this story and we added no reporting of our own to it.
About this story
As published by WSB-TV (ABC) - News . The Atlanta selects stories from publishers’ feeds, summarises them, and links back to the publisher that reported them. We add no reporting of our own. We attribute every source, link to the original report, and follow a documented editorial standards policy. To understand how stories are selected and reviewed, read our about page .
For the complete original report, visit WSB-TV (ABC) - News . Have a tip or correction? Contact the editor .
Category: safety Published: August 26, 2026 Source: WSB-TV (ABC) - News Reading time: 1 min
Frequently asked about this story
What is this story about? A recall has been issued for a thyroid pill due to concerns it may be "superpotent". The recall affects 30-milligram thyroid tablets, specifically Lot 504950, which was distributed nationwide. This…
When was this published? This article was first published on August 26, 2026 by WSB-TV (ABC) - News and curated for The Atlanta readers.
Who reported this story? This story was reported by Bob D'Angelo, Cox Media Group National Content Desk at WSB-TV (ABC) - News. To learn more about how The Atlanta selects and reviews stories, see our editorial standards .
Where can I find related coverage? See more safety coverage from The Atlanta, or browse our daily briefing and topic hubs .
← Back to all news
More safety →
Today’s briefing
Subscribe to newsletter
